RECRUITINGOBSERVATIONAL
Measures of Respiratory Health Registry
About This Trial
There are many techniques that can allow for the quantification of lung function in children; some are being used clinically and others are under development. Many of these tools are available at BC Children's Hospital. This registry study will act as a central repository for the results of traditional and novel pulmonary function tests done at BC Children's Hospital to allow for future analysis.
Who May Be Eligible (Plain English)
Participants with CF
Who May Qualify:
-Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: i. A documented sweat chloride ≥ 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT).
ii. A documented genotype with two disease-causing mutations in the CFTR gene.
\- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Who Should NOT Join This Trial:
- Physical findings at the screening that would compromise the safety of the participant or the quality of the data (e.g. respiratory distress or work of breathing)
- Requirement of supplementary oxygen to maintain oxygen saturation above 95%
Participants with other Respiratory Disease
Who May Qualify:
- Physician-diagnosed lung disease
- willing to sign a consent form by participant, parent, or legal guardian
- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Exclusion criteria
- Physical findings at screening that would compromise the safety of the participant or the quality of the research data
- Requirement of supplementary oxygen to maintain oxygen saturation above 95%
Healthy Participants
- Inclusion criteria
- willing to sign a consent form by participant, parent, or legal guardian
- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Exclusion criteria
- Physical findings at screening that would compromise the safety of the participant or the quality of the research data
- Evidence of lung disease
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Participants with CF
Inclusion Criteria:
-Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: i. A documented sweat chloride ≥ 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT).
ii. A documented genotype with two disease-causing mutations in the CFTR gene.
\- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Exclusion Criteria:
* Physical findings at the screening that would compromise the safety of the participant or the quality of the data (e.g. respiratory distress or work of breathing)
* Requirement of supplementary oxygen to maintain oxygen saturation above 95%
Participants with other Respiratory Disease
Inclusion criteria:
* Physician-diagnosed lung disease
* Informed consent by participant, parent, or legal guardian
* In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Exclusion criteria
* Physical findings at screening that would compromise the safety of the participant or the quality of the research data
* Requirement of supplementary oxygen to maintain oxygen saturation above 95%
Healthy Participants
* Inclusion criteria
* Informed consent by participant, parent, or legal guardian
* In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing
Exclusion criteria
* Physical findings at screening that would compromise the safety of the participant or the quality of the research data
* Evidence of lung disease
Locations (1)
British Columbia Children's Hospital
Vancouver, British Columbia, Canada